Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on the BSE. The scrip opened at Rs. 412.15 and has touched a high and low of Rs. 418.00 and Rs. 412.15 respectively. So far 8167 shares were traded on the counter. The BSE … Read more
Glenmark Pharmaceuticals is currently trading at Rs. 398.00, up by 2.60 points or 0.66% from its previous closing of Rs. 395.40 on the BSE. The scrip opened at Rs. 396.60 and has touched a high and low of Rs. 403.00 and Rs. 392.65 respectively. So far 21781 shares were traded on the counter. The BSE … Read more
Glenmark Pharma is currently trading at Rs. 381.15, up by 1.25 points or 0.33% from its previous closing of Rs. 379.90 on the BSE. The scrip opened at Rs. 382.50 and has touched a high and low of Rs. 383.00 and Rs. 375.20 respectively. So far 55247 shares were traded on the counter. The BSE … Read more
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 457.85 and Rs. 445.00 respectively. So far 42623 shares were traded on the counter. The BSE … Read more
Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, the generic version of Ziac Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, … Read more